GlassScriptPhysician profile
Melissa J Phillips
NPI 1841277423
$6,633.53
in general payments reported to CMS, 2019-2025
47 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,278 · 2020: $750 · 2021: $1,724 · 2022: $1,148 · 2023: $1,229 · 2024: $390 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,734.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $663.71 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $555.18 | 2019-2023 | |
| Glaxosmithkline, LLC. | $453.70 | 2019-2024 | Shingrix, Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $445.92 | 2019-2023 | Ozempic, Rybelsus |
| Abbvie INC. | $438.56 | 2021-2025 | |
| Abbott Laboratories | $407.30 | 2019-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $367.26 | 2019-2024 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $349.59 | 2019-2024 | Jardiance |
| Amgen INC. | $330.26 | 2019-2024 | Repatha, Evenity, Prolia |
| Lilly USA, LLC | $298.91 | 2019-2024 | Mounjaro, Jardiance, Emgality |
| Amarin Pharma, INC. | $267.16 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $222.28 | 2019-2024 | Trulance, Xifaxan |
| Astrazeneca Pharmaceuticals LP | $191.61 | 2019-2024 | Airsupra, Farxiga |
| Merck Sharp & Dohme LLC | $158.71 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $120.49 | 2019-2023 | Xarelto |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.